10 Big Pharma smartphone apps; 5 Drug Delivery Companies to Watch;

Biotech IT News

> 10 Big Pharma smartphone apps. Slideshow

> 15 mobile apps in Life Sciences - 2012. Slideshow

> Fierce's Top 10 Biotech Techies. Special Report

> FDA dishes out long-awaited guidance on social media. Article

> Roche getting entire workforce to use Google Apps. Story

CRO News

> 'Dateline' exposé snares Indian CROs in an ethics 'sting'. More

> Report: 438 died in Indian clinical trials last year. Article

> Top Emerging CRO Markets. Special Report

> FierceCRO's Top 5 Strategic CRO/Pharma Partnerships. Special Report

> Top CRO executives predict industry's future. Story

Pharma Manufacturing News

> FDA report shows deep problems at closed Novartis Consumer Health plant. Story

> FDA ravages Sanofi vaccine sterility process in warning letter. More

> Fierce's 2012 Top 10 FDA Red Flags. Special Report

> Novartis says Nebraska plant to reopen midyear. Article

> Explosion, fire at Teva's Pliva plant turns deadly. More

Biotech Research News

> Fish oil wipes out leukemia in mice. More

> New compound nearly wipes out HIV in cells. Story

> Top 20 Research Institute Salaries. Special Report

> Meet cancer's latest enemy: grape seed extract. Article

> Fight colon cancer with veggies, plus 2 other discoveries. More

Drug Delivery News

> Fierce's 5 Drug Delivery Companies to Watch. Special Report

> Top 5 Insulin-Delivery Techs To Watch. Special Report

> Ex-Sanofi exec takes helm at Bob Langer startup. Article

> This could be the year of nanotech-enabled medicines. Editor's Corner

> Kala Pharmaceuticals, co-launched by MIT's Langer, snags $6.2M. More

Biomarkers News

> Inflammatory protein marks heart disease. Story

> Biomarkers rescue Amgen's MAb, support Roche's Avastin. More

> Qiagen signs diagnostic biomarker deals. Article

> Biomarker could quickly diagnose heart attack. Story

> Alzheimer's marker is seen in middle age. Item

Vaccines News

> Genocea's HSV-2 vax to hit the clinic. More

> 10 promising therapeutic vaccines 2012. Special Report

> 20 Top-selling Vaccines -- H1 2012. Special Report

> Breast cancer vaccine set for large-scale testing. Article

> MedImmune to cut 200 jobs, layoffs hit vax R&D. Story

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.